ZFP64: A Potential Drug Target and Biomarker (G55734)
ZFP64: A Potential Drug Target and Biomarker
Zinc finger proteins (ZFPs) are a family of non-coding RNAs that play a crucial role in gene regulation and are involved in various cellular processes. ZFP64, also known as ZFP64 zinc finger protein, is a ZFP that is expressed in various tissues and has been identified as a potential drug target and biomarker.
The zinc finger gene is a family of non-coding RNAs that contain a conserved zinc finger motif. This motif is responsible for the formation of a zinc ion-dependent protein-coding module. ZFPs can be classified into three subclasses based on their zinc finger architecture: N-terminal, middle, and C-terminal. ZFP64 falls into the middle subclass and contains a unique ZFP64 zinc finger gene that is composed of 214 amino acids.
ZFP64 is a protein that is expressed in various tissues, including brain, heart, liver, and muscle. It is highly conserved and has a low mutation rate, which suggests that it has a stable structure and function. ZFP64 is involved in various cellular processes, including cell adhesion, migration, and invasion. It is also involved in the regulation of cellular signaling pathways, including the TGF-β pathway.
As a potential drug target, ZFP64 is of interest because of its involvement in various cellular processes that are relevant to human disease. For example, ZFP64 is involved in the regulation of cell adhesion, which is important for the development and maintenance of tissues and organs. It is also involved in the regulation of cell migration and invasion, which are important for the formation of tissues and organs during development and wound healing. Additionally, ZFP64 is involved in the regulation of cellular signaling pathways, including the TGF-β pathway, which is important for cell growth, differentiation, and survival.
In addition to its potential as a drug target, ZFP64 is also a potential biomarker for various diseases. For example, ZFP64 has been identified as a potential biomarker for cancer, including breast, ovarian, and prostate cancers. This is because ZFP64 is expressed in these cancers and can be used as a protein biomarker for their detection and treatment. Additionally, ZFP64 has been identified as a potential biomarker for cardiovascular disease, including myocardial infarction and stroke. This is because ZFP64 is expressed in these conditions and can be used as a protein biomarker for their detection and treatment.
In conclusion, ZFP64 is a unique and conserved protein that is involved in various cellular processes and has the potential to be a drug target and biomarker. Its involvement in cell adhesion, migration, and invasion, as well as its involvement in cellular signaling pathways, make it an attractive target for drug development. Additionally, its potential as a biomarker for cancer and cardiovascular disease make it a valuable tool for the development of new diagnostic and therapeutic approaches. Further research is needed to fully understand the role of ZFP64 in these processes and to determine its potential as a drug target and biomarker.
Protein Name: ZFP64 Zinc Finger Protein
Functions: May be involved in the regulation of mesenchymal cell differentiation through transactivation of NOTCH1 target genes
The "ZFP64 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZFP64 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
ZFP64P1 | ZFP69 | ZFP69B | ZFP82 | ZFP90 | ZFP91 | ZFP91-CNTF | ZFP92 | ZFPL1 | ZFPM1 | ZFPM2 | ZFPM2-AS1 | ZFR | ZFR2 | ZFTA | ZFTRAF1 | ZFX | ZFX-AS1 | ZFY | ZFYVE1 | ZFYVE16 | ZFYVE19 | ZFYVE21 | ZFYVE26 | ZFYVE27 | ZFYVE28 | ZFYVE9 | ZFYVE9P1 | ZG16 | ZG16B | ZGLP1 | ZGPAT | ZGRF1 | ZHX1 | ZHX1-C8orf76 | ZHX2 | ZHX3 | ZIC1 | ZIC2 | ZIC3 | ZIC4 | ZIC5 | ZIK1 | ZIM2 | ZIM3 | Zinc finger protein GLI | ZKSCAN1 | ZKSCAN2 | ZKSCAN3 | ZKSCAN4 | ZKSCAN5 | ZKSCAN7 | ZKSCAN8 | ZKSCAN8P1 | ZMAT1 | ZMAT2 | ZMAT3 | ZMAT4 | ZMAT5 | ZMIZ1 | ZMIZ1-AS1 | ZMIZ2 | ZMPSTE24 | ZMYM1 | ZMYM2 | ZMYM3 | ZMYM4 | ZMYM4-AS1 | ZMYM5 | ZMYM6 | ZMYND10 | ZMYND11 | ZMYND12 | ZMYND15 | ZMYND19 | ZMYND8 | ZNF10 | ZNF100 | ZNF101 | ZNF106 | ZNF107 | ZNF112 | ZNF114 | ZNF117 | ZNF12 | ZNF121 | ZNF124 | ZNF131 | ZNF132 | ZNF133 | ZNF134 | ZNF135 | ZNF136 | ZNF137P | ZNF138 | ZNF14 | ZNF140 | ZNF141 | ZNF142 | ZNF143
